ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,733,575 | -8.8% | 2,522,686 | -0.8% | 0.00% | – |
| Q2 2023 | $4,092,720 | -82.9% | 2,542,062 | -69.1% | 0.00% | -100.0% |
| Q1 2023 | $23,888,672 | -52.4% | 8,237,473 | -46.2% | 0.00% | 0.0% |
| Q4 2022 | $50,182,294 | +64.0% | 15,299,480 | +88.9% | 0.00% | -50.0% |
| Q3 2022 | $30,608,000 | -36.8% | 8,097,353 | +30.1% | 0.00% | -33.3% |
| Q2 2022 | $48,467,000 | -16.8% | 6,221,686 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $58,282,000 | -14.5% | 6,273,617 | +45.1% | 0.00% | 0.0% |
| Q4 2021 | $68,149,000 | +0.7% | 4,324,199 | +14.4% | 0.00% | -25.0% |
| Q3 2021 | $67,678,000 | -0.4% | 3,780,897 | -13.5% | 0.00% | 0.0% |
| Q2 2021 | $67,982,000 | +7.3% | 4,371,856 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $63,367,000 | +8.2% | 4,412,774 | +47.9% | 0.00% | 0.0% |
| Q4 2020 | $58,585,000 | +39.9% | 2,984,441 | -7.6% | 0.00% | +33.3% |
| Q3 2020 | $41,874,000 | -12.0% | 3,231,040 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $47,584,000 | +149.0% | 3,265,858 | +45.4% | 0.00% | +50.0% |
| Q1 2020 | $19,111,000 | -47.3% | 2,245,710 | +2.1% | 0.00% | 0.0% |
| Q4 2019 | $36,242,000 | -1.5% | 2,200,472 | -15.6% | 0.00% | -33.3% |
| Q3 2019 | $36,801,000 | -21.0% | 2,606,271 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $46,568,000 | -30.8% | 2,315,658 | +36.7% | 0.00% | -40.0% |
| Q1 2019 | $67,338,000 | +15.1% | 1,694,026 | +0.6% | 0.01% | 0.0% |
| Q4 2018 | $58,528,000 | -32.8% | 1,684,733 | -20.0% | 0.01% | -28.6% |
| Q3 2018 | $87,070,000 | +12.8% | 2,105,716 | +0.2% | 0.01% | +16.7% |
| Q2 2018 | $77,191,000 | -1.4% | 2,100,488 | +4.6% | 0.01% | -14.3% |
| Q1 2018 | $78,317,000 | +875.1% | 2,008,067 | +352.4% | 0.01% | +600.0% |
| Q4 2017 | $8,032,000 | +12.6% | 443,821 | +3.0% | 0.00% | 0.0% |
| Q3 2017 | $7,136,000 | +20.2% | 431,050 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $5,936,000 | -53.0% | 423,943 | -31.0% | 0.00% | 0.0% |
| Q1 2017 | $12,634,000 | +48.2% | 614,785 | +2.4% | 0.00% | 0.0% |
| Q4 2016 | $8,526,000 | +8.0% | 600,521 | +62.8% | 0.00% | 0.0% |
| Q3 2016 | $7,894,000 | -1.3% | 368,980 | +3.9% | 0.00% | 0.0% |
| Q2 2016 | $7,995,000 | +57.5% | 355,001 | +33.1% | 0.00% | 0.0% |
| Q1 2016 | $5,077,000 | -68.0% | 266,752 | -55.7% | 0.00% | -50.0% |
| Q4 2015 | $15,889,000 | +434.3% | 601,687 | +740.2% | 0.00% | – |
| Q1 2015 | $2,974,000 | +193.0% | 71,612 | +88.6% | 0.00% | – |
| Q4 2014 | $1,015,000 | – | 37,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |